It also represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do. Finally, Deborah DiSanzo, global General Manager for IBM Watson Health, joined us … The Board has delegated some of its powers to four principal committees and the CEO.
Our leadership, which includes our Board of Directors and Senior Executive Team, is accountable to our shareholders for the responsible conduct of the business and our long-term success. Ms. McCoy holds a Bachelor of Science degree in textile chemistry from the University of Massachusetts, Dartmouth, a Master’s degree in chemical engineering from Princeton University, and an MBA from Rutgers University. Ms McCoy will also become a member of the Audit Committee. She holds four US patents, and she has been on Fortune magazine’s “50 Most Powerful Women in Business” list.Copyright © 2020 Certara, USA. Nazneen Rahman is a renowned medical scientist and joined us in June. Prior to Avon, Ms. McCoy had a distinguished 30-year career at Johnson & Johnson serving as Vice Chairman of the Executive Committee, responsible for the Pharmaceutical and Consumer business segments that represented more than 60 percent of the company’s revenues. Member of the Board since April 2012 and Chairman since June 2012.Member of the Board and CFO since November 2013.You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.AstraZeneca provides this link as a service to website visitors. The Chief Executive Officer, Chief Financial Officer and SET also take the lead in developing our strategy for review, constructive challenge and approval by the Board as part of our annual strategy review process. Prior to Avon, Ms. McCoy had a distinguished 30-year career at Johnson & Johnson serving as Vice Chairman of the Executive Committee, responsible for the Pharmaceutical and Consumer business segments that represented more than 60 percent of the company’s revenues. Elle est également administratrice d’AstraZeneca plc, une entreprise mondiale de biopharmaceutique à visée scientifique. We encourage you to read the privacy policy of every website you visit.Member of the Board since April 2017Member of the Board since September 2019Member of the Board since April 2012.Member of the Board since April 2012 and Senior independent Non-Executive Director since January 2019.Member of the Board since December 2017Our leadership, which includes our Board of Directors and Senior Executive Team, is accountable to our shareholders for the responsible conduct of the business and our long-term success. Sheri McCoy was appointed in October and brings several decades of pharmaceutical industry experience from her time at Johnson & Johnson. Our CEO leads the SET and has executive responsibility for the management, development and performance of the business.
Ms. McCoy joined Johnson & Johnson as a scientist in research and development and subsequently managed businesses in every major product sector, including consumer, prescription medicines, and medical devices, where she held roles including Worldwide Chairman, Pharmaceuticals Group and Worldwide Chairman, Surgical Care Group. The Board is responsible for setting our strategy and policies, oversight of risk and corporate governance and monitoring progress towards meeting our annual plans. ASTRAZENECA APPOINTS SHERI MCCOY AND. Members of the Board and their biographies are shown below.Member of the Board since April 1999.Member of the Board and CEO since October 2012.Member of the Board since October 2017.Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.Member of the Board since January 2019Member of the Board since June 2017.In addition to the Board of Directors, our Senior Executive Team, or SET, is the body through which our Chief Executive Officer (CEO) exercises the authority delegated to him by the Board.
DEBORAH DISANZO TO ITS BOARD.